Abstract
Sexual dysfunction is one of the most common, distressing and persistent adverse effects of prostate cancer treatment, and has a profound effect on quality of life for the patient and his partner. Current health-care provisions are inadequate to address the demand for the management of sexual dysfunction, with approximately half of prostate cancer survivors reporting unmet sexual health-care needs. Management strategies predominately involve pharmacological interventions to address the direct physiological effects of prostate cancer treatment on erectile function. However, the aetiology of sexual dysfunction is multifaceted and considerable physiological and psychological adverse effects of prostate cancer treatments, which are not addressed by pharmacological intervention, contribute to sexual dysfunction. Exercise has established efficacy for improving many of these factors in men with prostate cancer, including changes in body composition (especially to counteract body feminization), fatigue, physical function, risk of comorbid conditions, depression, anxiety and quality of life. Emerging evidence indicates that exercise also has a positive effect on sexual desire and sexual activity in men with prostate cancer.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Australian Institute of Health and Welfare & Australasian Association of Cancer Registries. Cancer in Australia: an overview 2012 [online], (2012).
Sanda, M. G. et al. Quality of life and satisfaction with outcome among prostate-cancer survivors. N. Engl. J. Med. 358, 1250–1261 (2008).
Bober, S. L. & Varela, V. S. Sexuality in Adult Cancer Survivors: Challenges and Intervention. J. Clin. Oncol. 30, 3712–3719 (2012).
Sadovsky, R. et al. Cancer and sexual problems. J. Sex. Med. 7, 349–373 (2010).
Resnick, M. J. et al. Long-term functional outcomes after treatment for localized prostate cancer. N. Engl. J. Med. 368, 436–445 (2013).
Stanford, J. L. et al. Urinary and sexual function after radical prostatectomy for clinically localized prostate cancer: the Prostate Cancer Outcomes Study. JAMA 283, 354–360 (2000).
Spry, N. A. et al. Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer. Eur. J. Cancer 42, 1083–1092 (2006).
Hamilton, A. S. et al. Health outcomes after external-beam radiation therapy for clinically localized prostate cancer: results from the Prostate Cancer Outcomes Study. J. Clin. Oncol. 19, 2517–2526 (2001).
Parker, W. R., Wang, R., He, C. & Wood, D. P. Jr. Five year expanded prostate cancer index composite-based quality of life outcomes after prostatectomy for localized prostate cancer. BJU Int. 107, 585–590 (2011).
Higano, C. S. Sexuality and Intimacy After Definitive Treatment and Subsequent Androgen Deprivation Therapy for Prostate Cancer. J. Clin. Oncol. 30, 3720–3725 (2012).
Ng, E. et al. The Influence of Testosterone Suppression and Recovery on Sexual Function in Men With Prostate Cancer: Observations From a Prospective Study in Men Undergoing Intermittent Androgen Suppression. J. Urol. 187, 2162–2167 (2012).
Elliott, S., Latini, D. M., Walker, L. M., Wassersug, R. & Robinson, J. W. Androgen Deprivation Therapy for Prostate Cancer: Recommendations to Improve Patient and Partner Quality of Life. J. Sex. Med. 7, 2996–3010 (2010).
Reese, J. B. Coping with sexual concerns after cancer. Curr. Opin. Oncol. 23, 313–321 (2011).
Penson, D. F. et al. Is Quality of Life Different for Men with Erectile Dysfunction and Prostate Cancer Compared to Men with Erectile Dysfunction Due to Other Causes? Results from the ExCEED Data Base. J. Urol. 169, 1458–1461 (2003).
Singer, P. A. et al. Sex or survival: trade-offs between quality and quantity of life. J. Clin. Oncol. 9, 328–334 (1991).
Smith, D. P. et al. Age, Health, and Education Determine Supportive Care Needs of Men Younger Than 70 Years With Prostate Cancer. J. Clin. Oncol. 25, 2560–2566 (2007).
Miles, C. L. et al. Interventions for sexual dysfunction following treatments for cancer. Cochrane Database Syst. Rev. Issue 4. Art. No.: CD005540 http://dx.doi.10.1002/14651858.CD005540.pub2 (2007).
Magheli, A. & Burnett, A. L. Erectile dysfunction following prostatectomy: prevention and treatment. Nat. Rev. Urol. 6, 415–427 (2009).
Ottenbacher, A. et al. Cancer-Specific Concerns and Physical Activity Among Recently Diagnosed Breast and Prostate Cancer Survivors. Integr. Cancer Ther. 12, 206–212 (2013).
Bacon, C. G. et al. Sexual function in men older than 50 years of age: results from the health professionals follow-up study. Ann. Intern. Med. 139, 161–168 (2003).
Weber, M. F. et al. Risk factors for erectile dysfunction in a cohort of 108,477 Australian men. Med. J. Aust. 199, 107–111 (2013).
Poston, D. L. & Baumle, A. K. Patterns of asexuality in the United States. Demographic Res. 23, 509–530 (2010).
Seftel, A. D. Erectile Dysfunction in the Elderly: Epidemiology, Etiology and Approaches to Treatment. J. Urol. 169, 1999–2007 (2003).
Derby, C. A. et al. Modifiable risk factors and erectile dysfunction: can lifestyle changes modify risk? Urology 56, 302–306 (2000).
Bacon, C. G. et al. A Prospective Study of Risk Factors for Erectile Dysfunction. J. Urol. 176, 217–221 (2006).
Sharifi, N., Gulley, J. L. & Dahut, W. L. Androgen deprivation therapy for prostate cancer. JAMA 294, 238–244 (2005).
Collier, A., Ghosh, S., McGlynn, B. & Hollins, G. Prostate cancer, androgen deprivation therapy, obesity, the metabolic syndrome, type 2 diabetes, and cardiovascular disease: a review. Am. J. Clin. Oncol. 35, 504–509 (2012).
Galvao, D. A., Taaffe, D. R., Spry, N. & Newton, R. U. Exercise can prevent and even reverse adverse effects of androgen suppression treatment in men with prostate cancer. Prostate Cancer Prostatic Dis. 10, 340–346 (2007).
Levine, G. N. et al. Androgen-deprivation therapy in prostate cancer and cardiovascular risk: a science advisory from the American Heart Association, American Cancer Society, and American Urological Association: endorsed by the American Society for Radiation Oncology. Circulation 121, 833–840 (2010).
Zaider, T., Manne, S., Nelson, C., Mulhall, J. & Kissane, D. Loss of Masculine Identity, Marital Affection, and Sexual Bother in Men with Localized Prostate Cancer. J. Sex. Med. 9, 2724–2732 (2012).
Klaeson, K., Sandell, K. & Bertero, C. M. Sexuality in the context of prostate cancer narratives. Qual. Health Res. 22, 1184–1194 (2012).
Hoyt, M. A., Stanton, A. L., Irwin, M. R. & Thomas, K. S. Cancer-related masculine threat, emotional approach coping, and physical functioning following treatment for prostate cancer. Health Psychol. 32, 66–74 (2013).
Peltier, A., van Velthoven, R. & Roumeguère, T. Current management of erectile dysfunction after cancer treatment. Curr. Opin. Oncol. 21, 303–309 (2009).
Burnett, A. L. Erectile Dysfunction. J. Urol. 175, S25–S31 (2006).
Wespes, E. et al. EAU Guidelines on Erectile Dysfunction: An Update. Eur. Urol. 49, 806–815 (2006).
Schover, L. R. et al. The use of treatments for erectile dysfunction among survivors of prostate carcinoma. Cancer 95, 2397–2407 (2002).
Stephenson, R. A. et al. Treatment of erectile dysfunction following therapy for clinically localized prostate cancer: patient reported use and outcomes from the Surveillance, Epidemiology, and End Results Prostate Cancer Outcomes Study. J. Urol. 174, 646–650 (2005).
Tal, R., Jacks, L. M., Elkin, E. & Mulhall, J. P. Penile implant utilization following treatment for prostate cancer: analysis of the SEER-Medicare database. J. Sex. Med. 8, 1797–1804 (2011).
Nelson, C. J., Deveci, S., Stasi, J., Scardino, P. T. & Mulhall, J. P. Sexual bother following radical prostatectomy. J. Sex. Med. 7, 129–135 (2010).
Brotto, L. A., Yule, M. & Breckon, E. Psychological interventions for the sexual sequelae of cancer: a review of the literature. J. Cancer Surviv. 4, 346–360 (2010).
Melnik, T., Soares, B. G. & Nasselo, A. G. Psychosocial interventions for erectile dysfunction. Cochrane Database of Systematic Reviews, Issue 9. Art. No.: CD004825. http://dx.doi.org/10.1002/14651858.CD004825.pub2 (2007).
Faller, H. et al. Effects of Psycho-Oncologic Interventions on Emotional Distress and Quality of Life in Adult Patients With Cancer: Systematic Review and Meta-Analysis. J. Clin. Oncol. 31, 782–793 (2013).
Chambers, S. K., Pinnock, C., Lepore, S. J., Hughes, S. & O'Connell, D. L. A systematic review of psychosocial interventions for men with prostate cancer and their partners. Patient Educ. Couns. 85, e75–e88 (2011).
La Vignera, S., Condorelli, R., Vicari, E., D'Agata, R. & Calogero, A. E. Physical activity and erectile dysfunction in middle-aged men. J. Androl. 33, 154–161 (2012).
Segal, R. J. et al. Randomized controlled trial of resistance or aerobic exercise in men receiving radiation therapy for prostate cancer. J. Clin. Oncol. 27, 344–351 (2009).
Schmitz, K. H. et al. American College of Sports Medicine roundtable on exercise guidelines for cancer survivors. Med. Sci. Sports Exerc. 42, 1409–1426 (2010).
Galvao, D. A., Taaffe, D. R., Spry, N., Joseph, D. & Newton, R. U. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J. Clin. Oncol. 28, 340–347 (2010).
Galvao, D. A., Taaffe, D. R., Spry, N. & Newton, R. U. Physical activity and genitourinary cancer survivorship. Recent Results Cancer Res. 186, 217–236 (2011).
Maas, R., Schwedhelm, E., Albsmeier, J. & Boger, R. H. The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function. Vasc. Med. 7, 213–225 (2002).
Nicolosi, A., Moreira, E. D. Jr, Shirai, M., Bin Mohd Tambi, M. I. & Glasser, D. B. Epidemiology of erectile dysfunction in four countries: cross-national study of the prevalence and correlates of erectile dysfunction. Urology 61, 201–226 (2003).
Pinnock, C. B., Stapleton, A. M. & Marshall, V. R. Erectile dysfunction in the community: a prevalence study. Med. J. Aust. 171, 353–357 (1999).
Hsiao, W. et al. Exercise is associated with better erectile function in men under 40 as evaluated by the International Index of Erectile Function. J. Sex. Med. 9, 524–530 (2012).
White, J. R., Case, D. A., McWhirter, D. & Mattison, A. M. Enhanced sexual behavior in exercising men. Arch. Sex. Behav. 19, 193–209 (1990).
Dahn, J. R. et al. Physical activity and sexual functioning after radiotherapy for prostate cancer: beneficial effects for patients undergoing external beam radiotherapy. Urology 65, 953–958 (2005).
Maio, G., Saraeb, S. & Marchiori, A. Physical activity and PDE5 inhibitors in the treatment of erectile dysfunction: results of a randomized controlled study. J. Sex. Med. 7, 2201–2208 (2010).
Lamina, S., Okoye, C. G. & Dagogo, T. T. Therapeutic effect of an interval exercise training program in the management of erectile dysfunction in hypertensive patients. J. Clin. Hypertens. (Greenwich) 11, 125–129 (2009).
Khoo, J. et al. Comparing Effects of Low- and High-Volume Moderate-Intensity Exercise on Sexual Function and Testosterone in Obese Men. J. Sex. Med. 10, 1823–1832 (2013).
Esposito, K. et al. Effect of lifestyle changes on erectile dysfunction in obese men: a randomized controlled trial. JAMA 291, 2978–2984 (2004).
Esposito, K. et al. Effects of Intensive Lifestyle Changes on Erectile Dysfunction in Men. J. Sex. Med. 6, 243–250 (2009).
Cormie, P. et al. Exercise maintains sexual activity in men undergoing androgen suppression for prostate cancer: a randomized controlled trial. Prostate Cancer Prostatic Dis. 16, 170–175 (2013).
Newton, R. U. et al. A phase III clinical trial of exercise modalities on treatment side-effects in men receiving therapy for prostate cancer. BMC Cancer 9, 210 (2009).
Chambers, S. K. et al. ProsCan for Couples: Randomised controlled trial of a couples-based sexuality intervention for men with localised prostate cancer who receive radical prostatectomy. BMC Cancer 8, 226 (2008).
Chambers, S. K. et al. Couple Distress after Localised Prostate Cancer. Support Care Cancer http://dx.doi:10.1007/s00520-013-1868-6.
Rock, C. L. et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J. Clin. 62, 242–274 (2012).
Smith, W. A., Nolan, V. G., Robison, L. L., Hudson, M. M. & Ness, K. K. Physical activity among cancer survivors and those with no history of cancer- a report from the National Health and Nutrition Examination Survey 2003 2006. Am. J. Transl. Res. 3, 342–350 (2011).
Blanchard, C. M., Courneya, K. S. & Stein, K. Cancer survivors' adherence to lifestyle behavior recommendations and associations with health-related quality of life: results from the American Cancer Society's SCS-II. J. Clin. Oncol. 26, 2198–2204 (2008).
Kwon, S., Hou, N. & Wang, M. Comparison of physical activity levels between cancer survivors and non-cancer participants in the 2009 BRFSS. J. Cancer Surviv. 6, 54–62 (2012).
Humphries, B., Duncan, M. J. & Mummery, W. K. Prevalence and correlates of resistance training in a regional Australian population. Br. J. Sports Med. 44, 653–656 (2010).
Centers for Disease Control and Prevention (CDC). Trends in strength training--United States, 1998–2004. MMWR Morb. Mortal. Wkly Rep. 55, 769–772 (2006).
Pinto, B. M. & Ciccolo, J. T. in Physical Activity and Cancer (eds Courneya, K. S. & Friedenreich, C. M.) 367–87 (Springer, London, 2011).
Blaney, J. M., Lowe-Strong, A., Rankin-Watt, J., Campbell, A. & Gracey, J. H. Cancer survivors' exercise barriers, facilitators and preferences in the context of fatigue, quality of life and physical activity participation: a questionnaire-survey. Psychooncology 22, 186–194 (2013).
Acknowledgements
P. Cormie is supported by the Cancer Council Western Australia Postdoctoral Research Fellowship. D. A. Galvão is funded by a Movember New Directions Development Award obtained through Prostate Cancer Foundation of Australia's Research Programme.
Author information
Authors and Affiliations
Contributions
P. Cormie researched data for the article and wrote the manuscript. All authors made a substantial contribution to discussions of content, and reviewed and edited the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Cormie, P., Newton, R., Taaffe, D. et al. Exercise therapy for sexual dysfunction after prostate cancer. Nat Rev Urol 10, 731–736 (2013). https://doi.org/10.1038/nrurol.2013.206
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrurol.2013.206
This article is cited by
-
Sexual function and rehabilitation after radiation therapy for prostate cancer: a review
International Journal of Impotence Research (2021)
-
Effects of resistance exercise in prostate cancer patients
Wiener klinische Wochenschrift (2020)
-
Perceptions of masculinity and body image in men with prostate cancer: the role of exercise
Supportive Care in Cancer (2018)
-
The use of exercise interventions to overcome adverse effects of androgen deprivation therapy
Nature Reviews Urology (2016)
-
Long-term health-related quality of life of prostate cancer survivors varies by primary treatment. Results from the PiCTure (Prostate Cancer Treatment, your experience) study
Journal of Cancer Survivorship (2015)